Skip to main content
Top
Published in: Quality of Life Research 3/2022

Open Access 01-03-2022

Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale

Authors: Susanne Singer, Eva Hammerlid, Iwona M. Tomaszewska, Cecilie Delphin Amdal, Kristin Bjordal, Bente Brokstad Herlofson, Marcos Santos, Joaquim Castro Silva, Hisham Mehanna, Amy Fullerton, Christine Brannan, Loreto Fernandez Gonzalez, Johanna Inhestern, Monica Pinto, Juan I. Arraras, Noam Yarom, Pierluigi Bonomo, Ingo Baumann, Razvan Galalae, Ourania Nicolatou-Galitis, Naomi Kiyota, Judith Raber-Durlacher, Dina Salem, Alexander Fabian, Andreas Boehm, Sanja Krejovic-Trivic, Wei-Chu Chie, Katherine Taylor, Christian Simon, Lisa Licitra, Allen C. Sherman, the EORTC Quality of Life Group and the EORTC Head and Neck Cancer Group

Published in: Quality of Life Research | Issue 3/2022

Login to get access

Abstract

Purpose

The aim of this study was to explore what methods should be used to determine the minimal important difference (MID) and minimal important change (MIC) in scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43.

Methods

In an international multi-centre study, patients with head and neck cancer completed the EORTC QLQ-HN43 before the onset of treatment (t1), three months after baseline (t2), and six months after baseline (t3). The methods explored for determining the MID were: (1) group comparisons based on performance status; (2) 0.5 and 0.3 standard deviation and standard error of the mean. The methods examined for the MIC were patients' subjective change ratings and receiver-operating characteristics (ROC) curves, predictive modelling, standard deviation, and standard error of the mean. The EORTC QLQ-HN43 Swallowing scale was used to investigate these methods.

Results

From 28 hospitals in 18 countries, 503 patients participated. Correlations with the performance status were |r|< 0.4 in 17 out of 19 scales; hence, performance status was regarded as an unsuitable anchor. The ROC approach yielded an implausible MIC and was also discarded. The remaining approaches worked well and delivered MID values ranging from 10 to 14; the MIC for deterioration ranged from 8 to 16 and the MIC for improvement from − 3 to − 14.

Conclusions

For determining MIDs of the remaining scales of the EORTC QLQ-HN43, we will omit comparisons of groups based on the Karnofsky Performance Score. Other external anchors are needed instead. Distribution-based methods worked well and will be applied as a starting strategy for analyses. For the calculation of MICs, subjective change ratings, predictive modelling, and standard-deviation based approaches are suitable methods whereas ROC analyses seem to be inappropriate.
Appendix
Available only for authorised users
Literature
1.
go back to reference King, M. T. (2011). A point of minimal important difference (MID): A critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research, 11, 171–184.CrossRef King, M. T. (2011). A point of minimal important difference (MID): A critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research, 11, 171–184.CrossRef
2.
go back to reference Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56, 395–407.CrossRef Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56, 395–407.CrossRef
3.
go back to reference Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health-status: Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407–415.CrossRef Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health-status: Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407–415.CrossRef
4.
go back to reference Sloan, J. A., Cella, D., Frost, M., Guyatt, G. H., Sprangers, M., & Symonds, T. (2002). Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clinic Proceedings, 77, 367–370.CrossRef Sloan, J. A., Cella, D., Frost, M., Guyatt, G. H., Sprangers, M., & Symonds, T. (2002). Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clinic Proceedings, 77, 367–370.CrossRef
5.
go back to reference Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16, 139–144.CrossRef Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16, 139–144.CrossRef
6.
go back to reference Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Quality of Life Research, 11, 207–221.CrossRef Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Quality of Life Research, 11, 207–221.CrossRef
7.
go back to reference Ringash, J., O’Sullivan, B., Bezjak, A., & Redelmeier, D. A. (2007). Interpreting clinically significant changes in patient-reported outcomes. Cancer, 110, 196–202.CrossRef Ringash, J., O’Sullivan, B., Bezjak, A., & Redelmeier, D. A. (2007). Interpreting clinically significant changes in patient-reported outcomes. Cancer, 110, 196–202.CrossRef
8.
go back to reference Sloan, J. A., Frost, M. H., Berzon, R., Dueck, A., Guyatt, G., Moinpour, C., et al. (2006). The clinical significance of quality of life assessments in oncology: A summary for clinicians. Supportive Care in Cancer, 14, 988–998.CrossRef Sloan, J. A., Frost, M. H., Berzon, R., Dueck, A., Guyatt, G., Moinpour, C., et al. (2006). The clinical significance of quality of life assessments in oncology: A summary for clinicians. Supportive Care in Cancer, 14, 988–998.CrossRef
10.
go back to reference Lemieux, J., Beaton, D. E., Hogg-Johnson, S., Bordeleau, L. J., & Goodwin, P. J. (2007). Three methods for minimally important difference: No relationship was found with the net proportion of patients improving. Journal of Clinical Epidemiology, 60, 448–455.CrossRef Lemieux, J., Beaton, D. E., Hogg-Johnson, S., Bordeleau, L. J., & Goodwin, P. J. (2007). Three methods for minimally important difference: No relationship was found with the net proportion of patients improving. Journal of Clinical Epidemiology, 60, 448–455.CrossRef
11.
go back to reference Cocks, K., King, M. T., Velikova, G., de Castro, G., St James, M. M., Fayers, P. M., et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48, 1713–1721.CrossRef Cocks, K., King, M. T., Velikova, G., de Castro, G., St James, M. M., Fayers, P. M., et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48, 1713–1721.CrossRef
12.
go back to reference Musoro, Z. J., Hamel, J. F., Ediebah, D. E., Cocks, K., King, M. T., Groenvold, M., Sprangers, M. A., Brandberg, Y., Velikova, G., Maringwa, J., & Flechtner, H. H. (2018). Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: A meta-analysis protocol. British Medical Journal Open, 8, e019117. https://doi.org/10.1136/bmjopen-2017-019117CrossRef Musoro, Z. J., Hamel, J. F., Ediebah, D. E., Cocks, K., King, M. T., Groenvold, M., Sprangers, M. A., Brandberg, Y., Velikova, G., Maringwa, J., & Flechtner, H. H. (2018). Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: A meta-analysis protocol. British Medical Journal Open, 8, e019117. https://​doi.​org/​10.​1136/​bmjopen-2017-019117CrossRef
13.
go back to reference Kvam, A. K., Fayers, P., & Wisloff, F. (2010). What changes in health-related quality of life matter to multiple myeloma patients? A prospective study. European Journal of Haematology, 84, 345–353.CrossRef Kvam, A. K., Fayers, P., & Wisloff, F. (2010). What changes in health-related quality of life matter to multiple myeloma patients? A prospective study. European Journal of Haematology, 84, 345–353.CrossRef
14.
go back to reference Bedard, G., Zeng, L., Zhang, L. Y., Lauzon, N., Holden, L., Tsao, M., et al. (2016). Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients. Asia-Pacific Journal of Clinical Oncology, 12, E38–E46.CrossRef Bedard, G., Zeng, L., Zhang, L. Y., Lauzon, N., Holden, L., Tsao, M., et al. (2016). Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients. Asia-Pacific Journal of Clinical Oncology, 12, E38–E46.CrossRef
15.
go back to reference Raman, S., Ding, K. Y., Chow, E., Meyer, R. M., van der Linden, Y. M., Roos, D., et al. (2018). Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases. Quality of Life Research, 27, 1089–1098.CrossRef Raman, S., Ding, K. Y., Chow, E., Meyer, R. M., van der Linden, Y. M., Roos, D., et al. (2018). Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases. Quality of Life Research, 27, 1089–1098.CrossRef
16.
go back to reference Sully, K., Trigg, A., Bonner, N., Moreno-Koehler, A., Trennery, C., Shah, N., et al. (2019). Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patients. European Journal of Haematology, 103, 500–509.CrossRef Sully, K., Trigg, A., Bonner, N., Moreno-Koehler, A., Trennery, C., Shah, N., et al. (2019). Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patients. European Journal of Haematology, 103, 500–509.CrossRef
17.
go back to reference Reni, M., Braverman, J., Hendifar, A., Li, C. P., Mercade, T. M., Oh, D. Y., et al. (2019). Evaluation of minimal important difference (MID) for the European organisation for research and treatment of cancer (EORTC) pancreatic cancer module (PAN26) in patients with surgically resected pancreatic adenocarcinoma. Annals of Oncology, 30, 262.CrossRef Reni, M., Braverman, J., Hendifar, A., Li, C. P., Mercade, T. M., Oh, D. Y., et al. (2019). Evaluation of minimal important difference (MID) for the European organisation for research and treatment of cancer (EORTC) pancreatic cancer module (PAN26) in patients with surgically resected pancreatic adenocarcinoma. Annals of Oncology, 30, 262.CrossRef
18.
go back to reference Singer, S., Amdal, C. D., Hammerlid, E., Tomaszewska, I. M., Silva, J. C., Mehanna, H., et al. (2019). International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head and Neck, 41, 1725–1737.CrossRef Singer, S., Amdal, C. D., Hammerlid, E., Tomaszewska, I. M., Silva, J. C., Mehanna, H., et al. (2019). International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head and Neck, 41, 1725–1737.CrossRef
19.
go back to reference Singer, S., Araújo, C., Arraras, J., Baumann, I., Boehm, A., Herlofson, B. B., et al. (2015). Measuring quality of life in head and neck Cancer patients: Update of the EORTC QLQ-H&N Module Phase III. Head and Neck, 37, 1358–1367.CrossRef Singer, S., Araújo, C., Arraras, J., Baumann, I., Boehm, A., Herlofson, B. B., et al. (2015). Measuring quality of life in head and neck Cancer patients: Update of the EORTC QLQ-H&N Module Phase III. Head and Neck, 37, 1358–1367.CrossRef
20.
go back to reference Singer, S., Arraras, J., Baumann, I., Boehm, A., Chie, W. C., Galalae, R., et al. (2013). Quality of life in head and neck cancer patients receiving multimodal or targeted therapy: Update of the EORTC QLQ-H&N35 Phase I. Head and Neck, 35, 1331–1338.CrossRef Singer, S., Arraras, J., Baumann, I., Boehm, A., Chie, W. C., Galalae, R., et al. (2013). Quality of life in head and neck cancer patients receiving multimodal or targeted therapy: Update of the EORTC QLQ-H&N35 Phase I. Head and Neck, 35, 1331–1338.CrossRef
21.
go back to reference Singer, S., Arraras, J., Chie, W. C., Fisher, S., Galalae, R., Hammerlid, E., et al. (2013). Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35. A methodological review. Quality of Life Research, 22, 1927–1941.CrossRef Singer, S., Arraras, J., Chie, W. C., Fisher, S., Galalae, R., Hammerlid, E., et al. (2013). Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35. A methodological review. Quality of Life Research, 22, 1927–1941.CrossRef
22.
go back to reference Bjordal, K., Ahlner-Elmqvist, M., Hammerlid, E., Boysen, M., Evensen, J. F., Biorklund, A., et al. (2001). A prospective study of quality of life in head and neck cancer patients Part II: Longitudinal Data. The Laryngoscope, 111, 1440–1452.CrossRef Bjordal, K., Ahlner-Elmqvist, M., Hammerlid, E., Boysen, M., Evensen, J. F., Biorklund, A., et al. (2001). A prospective study of quality of life in head and neck cancer patients Part II: Longitudinal Data. The Laryngoscope, 111, 1440–1452.CrossRef
23.
go back to reference Nordgren, M., Hammerlid, E., Bjordal, K., Ahlner-Elmqvist, M., Boysen, M., & Jannert, M. (2008). Quality of life in oral carcinoma: A 5-year prospective study. Head & Neck, 30, 461–470.CrossRef Nordgren, M., Hammerlid, E., Bjordal, K., Ahlner-Elmqvist, M., Boysen, M., & Jannert, M. (2008). Quality of life in oral carcinoma: A 5-year prospective study. Head & Neck, 30, 461–470.CrossRef
24.
go back to reference Abendstein, H., Nordgren, M., Boysen, M., Jannert, M., Silander, E. M., Ahlner-Elmqvist, M., Hammerlid, E., & Bjordal, K. (2005). Quality of life and head and neck cancer: A 5 year prospective study. The Laryngoscope, 115, 2183–2192.CrossRef Abendstein, H., Nordgren, M., Boysen, M., Jannert, M., Silander, E. M., Ahlner-Elmqvist, M., Hammerlid, E., & Bjordal, K. (2005). Quality of life and head and neck cancer: A 5 year prospective study. The Laryngoscope, 115, 2183–2192.CrossRef
25.
go back to reference Roick, J., Danker, H., Dietz, A., Papsdorf, K., & Singer, S. (2020). Predictors of changes in quality of life in head and neck cancer patients: A prospective study over a six-month period. European Archives of Oto-Rhino-Laryngology, 277, 559–567.CrossRef Roick, J., Danker, H., Dietz, A., Papsdorf, K., & Singer, S. (2020). Predictors of changes in quality of life in head and neck cancer patients: A prospective study over a six-month period. European Archives of Oto-Rhino-Laryngology, 277, 559–567.CrossRef
26.
go back to reference Taylor, K., & Singer, S. (2019). Long-term quality of life in head and neck cancer patients A systematic review. Der Onkologe, 25, 125–131.CrossRef Taylor, K., & Singer, S. (2019). Long-term quality of life in head and neck cancer patients A systematic review. Der Onkologe, 25, 125–131.CrossRef
27.
go back to reference Singer, S., Danker, H., Guntinas-Lichius, O., Oeken, J., Pabst, F., Schock, J., Vogel, H. J., Meister, E. F., Wulke, C., Dietz, A., et al. (2014). Quality of life before and after total laryngectomy: Results of a multi-centre prospective cohort study. Head and Neck, 36, 359–368.CrossRef Singer, S., Danker, H., Guntinas-Lichius, O., Oeken, J., Pabst, F., Schock, J., Vogel, H. J., Meister, E. F., Wulke, C., Dietz, A., et al. (2014). Quality of life before and after total laryngectomy: Results of a multi-centre prospective cohort study. Head and Neck, 36, 359–368.CrossRef
28.
go back to reference Aaronson, N., Ahmedzai, S., Bergmann, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.CrossRef Aaronson, N., Ahmedzai, S., Bergmann, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.CrossRef
29.
go back to reference Fayers, P. M., & Machin, D. (2007). Quality of Life (2nd ed.). Chichester: Wiley.CrossRef Fayers, P. M., & Machin, D. (2007). Quality of Life (2nd ed.). Chichester: Wiley.CrossRef
30.
go back to reference Devji, T., Carrasco-Labra, A., Qasim, A., Phillips, M., Johnston, B. C., Devasenapathy, N., Zeraatkar, D., Bhatt, M., Jin, X., Brignardello-Petersen, R., & Urquhart, O. (2020). Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study. British Medical Journal, 369, 1714.CrossRef Devji, T., Carrasco-Labra, A., Qasim, A., Phillips, M., Johnston, B. C., Devasenapathy, N., Zeraatkar, D., Bhatt, M., Jin, X., Brignardello-Petersen, R., & Urquhart, O. (2020). Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study. British Medical Journal, 369, 1714.CrossRef
31.
go back to reference Youden, W. J. (1950). Index for rating diagnostic tests. Cancer, 3, 32–35.CrossRef Youden, W. J. (1950). Index for rating diagnostic tests. Cancer, 3, 32–35.CrossRef
32.
go back to reference Terluin, B., Eekhout, I., Terwee, C., & De Vet, H. C. W. (2015). Minimal important chnge (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis. Journal of Clinical Epidemiology, 68, 1388–1396.CrossRef Terluin, B., Eekhout, I., Terwee, C., & De Vet, H. C. W. (2015). Minimal important chnge (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis. Journal of Clinical Epidemiology, 68, 1388–1396.CrossRef
33.
go back to reference Crary, M. A., Mann, G. D. C., & Groher, M. E. (2005). Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Archives of Physical Medicine and Rehabilitation, 86, 1516–1520.CrossRef Crary, M. A., Mann, G. D. C., & Groher, M. E. (2005). Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Archives of Physical Medicine and Rehabilitation, 86, 1516–1520.CrossRef
34.
go back to reference Rosenbek, J. C., Robbins, J. A., Roecker, E. B., Coyle, J. L., & Wood, J. L. (1996). A penetration aspiration scale. Dysphagia, 11, 93–98.CrossRef Rosenbek, J. C., Robbins, J. A., Roecker, E. B., Coyle, J. L., & Wood, J. L. (1996). A penetration aspiration scale. Dysphagia, 11, 93–98.CrossRef
35.
go back to reference Hutcheson, K. A., Barrow, M. P., Barringer, D. A., Knott, J. K., Lin, H. Y., Weber, R. S., et al. (2017). Dynamic imaging grade of swallowing toxicity (DIGEST): Scale development and validation. Cancer, 123, 62–70.CrossRef Hutcheson, K. A., Barrow, M. P., Barringer, D. A., Knott, J. K., Lin, H. Y., Weber, R. S., et al. (2017). Dynamic imaging grade of swallowing toxicity (DIGEST): Scale development and validation. Cancer, 123, 62–70.CrossRef
36.
go back to reference Chen, A. Y., Frankowski, R., Bishop-Leone, J., Hebert, T., Leyk, S., Lewin, J., et al. (2001). The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: The M. D Anderson dysphagia inventory. Archives of Otolaryngology-Head & Neck Surgery, 127, 870–876. Chen, A. Y., Frankowski, R., Bishop-Leone, J., Hebert, T., Leyk, S., Lewin, J., et al. (2001). The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: The M. D Anderson dysphagia inventory. Archives of Otolaryngology-Head & Neck Surgery, 127, 870–876.
37.
go back to reference Carnaby, G. D., & Crary, M. A. (2014). Development and validation of a cancer-specific swallowing assessment tool: MASA-C. Supportive Care in Cancer, 22, 595–602.CrossRef Carnaby, G. D., & Crary, M. A. (2014). Development and validation of a cancer-specific swallowing assessment tool: MASA-C. Supportive Care in Cancer, 22, 595–602.CrossRef
38.
go back to reference Cocks, K., Velikova, G., King, M. T., Fayers, P. M., & Brown, J. M. (2014). Can individual patients assess differences in quality of life between groups of patients? European Journal of Cancer Care, 23, 228–238.CrossRef Cocks, K., Velikova, G., King, M. T., Fayers, P. M., & Brown, J. M. (2014). Can individual patients assess differences in quality of life between groups of patients? European Journal of Cancer Care, 23, 228–238.CrossRef
39.
go back to reference Bindewald, J., Herrmann, E., Dietz, A., Wulke, C., Meister, E. F., Wollbruck, D. et al. (2007). Quality of life and voice intelligibility in laryngeal cancer patients: Relevance of the "satisfaction paradox". [German], Laryngo- Rhino- Otologie 86, 426-430 Bindewald, J., Herrmann, E., Dietz, A., Wulke, C., Meister, E. F., Wollbruck, D. et al. (2007). Quality of life and voice intelligibility in laryngeal cancer patients: Relevance of the "satisfaction paradox". [German], Laryngo- Rhino- Otologie 86, 426-430
40.
go back to reference Schwartz, C. E., Bode, R., Repucci, N., Becker, J., Sprangers, M. A., & Fayers, P. (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research, 15, 1533–1550.CrossRef Schwartz, C. E., Bode, R., Repucci, N., Becker, J., Sprangers, M. A., & Fayers, P. (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research, 15, 1533–1550.CrossRef
41.
go back to reference Sprangers, M. A., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: A theoretical model. Social Science and Medicine, 48, 1507–1515.CrossRef Sprangers, M. A., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: A theoretical model. Social Science and Medicine, 48, 1507–1515.CrossRef
42.
go back to reference Giesinger, J. M., Aaronson, N. K., Arraras, J. I., Efficace, F., Groenvold, M., Kieffer, J. M., et al. (2018). A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important. Psycho-Oncology, 27, 548–555.CrossRef Giesinger, J. M., Aaronson, N. K., Arraras, J. I., Efficace, F., Groenvold, M., Kieffer, J. M., et al. (2018). A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important. Psycho-Oncology, 27, 548–555.CrossRef
43.
go back to reference Fahsl, S., Keszte, J., Boehm, A., Vogel, H.-J., Völkel, W., Meister, E. F., et al. (2012). Clinical relevance of quality of life data in laryngectomized patients. The Laryngoscope, 122, 1532–1538.CrossRef Fahsl, S., Keszte, J., Boehm, A., Vogel, H.-J., Völkel, W., Meister, E. F., et al. (2012). Clinical relevance of quality of life data in laryngectomized patients. The Laryngoscope, 122, 1532–1538.CrossRef
Metadata
Title
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
Authors
Susanne Singer
Eva Hammerlid
Iwona M. Tomaszewska
Cecilie Delphin Amdal
Kristin Bjordal
Bente Brokstad Herlofson
Marcos Santos
Joaquim Castro Silva
Hisham Mehanna
Amy Fullerton
Christine Brannan
Loreto Fernandez Gonzalez
Johanna Inhestern
Monica Pinto
Juan I. Arraras
Noam Yarom
Pierluigi Bonomo
Ingo Baumann
Razvan Galalae
Ourania Nicolatou-Galitis
Naomi Kiyota
Judith Raber-Durlacher
Dina Salem
Alexander Fabian
Andreas Boehm
Sanja Krejovic-Trivic
Wei-Chu Chie
Katherine Taylor
Christian Simon
Lisa Licitra
Allen C. Sherman
the EORTC Quality of Life Group and the EORTC Head and Neck Cancer Group
Publication date
01-03-2022
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 3/2022
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02939-6

Other articles of this Issue 3/2022

Quality of Life Research 3/2022 Go to the issue